October 13, 2021 Clinical Research/Diagn. M&A, Partnerships

GE Healthcare Partners with Apprise Health Insights to Launch Nation's First Automated Statewide Hospital Bed Management Solution in Oregon

First-of-its-kind tool actively manages hospital data, providing near real-time occupancy information that enables hospitals to maximize resources Saved participating hospitals 45,000 hours of labor, amounting to $3 million dollars, by eliminating the need for manual entry of capacity data Puts actionable data in the hands of decision-makers so that statewide capacity can be optimized, allowing... Read more

October 6, 2021 Clinical Research/Diagn. Lab Top-10

PerkinElmer’s Horizon Discovery CHOSOURCE™ Platform Expanding To Include CHO-K1 ADCC+ Expression Cell Line for Development of Therapeutic Antibodies in Oncology, Infectious Disease and Autoimmune Conditions

Existing CHO platform, featuring low cost and no royalty or license tie-ins, expands with new cell line to help develop biotherapeutics with increased potency and longevity and decreased side effects WALTHAM, Mass.– October 6, 2021, PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced that its Horizon Discovery CHOSOURCE™ platform is... Read more

September 30, 2021 Bio/Pharma/CRO Clinical Research/Diagn.

Phase II/III trial shows Ronapreve™ (casirivimab and imdevimab) significantly reduces viral load within seven days of treatment in patients hospitalised with COVID-19

Trial met primary endpoint, showing Ronapreve significantly reduced viral load in seronegative patients hospitalised with COVID-19 who did not require high-flow oxygen or mechanical ventilation at baseline Clinical data complement previous findings in hospitalised setting, including from United Kingdom (UK) University of Oxford-led RECOVERY trial Basel, 30 September 2021 – Roche (SIX: RO, ROG; OTCQX:... Read more

September 29, 2021 Acad, Gov/Utilities Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 PAI Top-10

Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology

Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology CARLSBAD, Calif., Sept. 29, 2021 /PRNewswire/ — To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its Oncomine Clinical Research Grant. The latest call for proposals aims to provide funding for... Read more

September 28, 2021 Atomic Spectroscopy Clinical Research/Diagn. Environ, Ag./Food & Bev Lab Top-10 Liq. Handling & Robotics Product Launch

Thermo Fisher Scientific Unveils New Clinical and Research Lab Innovations at AACC 2021

Thermo Fisher Scientific Unveils New Clinical and Research Lab Innovations at AACC 2021 New instruments, assays and controls improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell & gene therapy, autoimmune disease and drugs of abuse ATLANTA, Sept. 28, 2021 /PRNewswire/ — AACC 2021 –Thermo Fisher Scientific, the world leader in... Read more

September 15, 2021 Acad, Gov/Utilities Chromatography Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal Life Science Tools PAI Top-10

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda’s Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations Oncomine Dx Target Test now approved as CDx for five targeted NSCLC therapies in the U.S. CARLSBAD, Calif., Sept. 15, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher... Read more

September 14, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

09/14/2021 LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience,... Read more

September 13, 2021 Clinical Research/Diagn. Licensing, IP, and Legal Liq. Handling & Robotics

Quanterix Receives Label Expansion On Emergency Use Authorization For COVID Antigen Test

Simoa SARS-CoV-2 N Protein Antigen Test is first antigen test validated to detect all Variants of Concern currently designated by CDC, including Delta variant, and first authorized for use in saliva samples EUA label expansion demonstrates additional evidence showing potential for Simoa technology across range of clinical tests, including less-invasive testing BILLERICA, Mass., September 13,... Read more

September 10, 2021 Clinical Research/Diagn. Lab Top-10 PR/Corporate

Oncomine Dx Target Test Receives MHLW Approval as a Companion Diagnostic for Eli Lilly's RET-Inhibitor in Non-Small Cell Lung Cancer in Japan

Oncomine Dx Target Test Receives MHLW Approval as a Companion Diagnostic for Eli Lilly’s RET-Inhibitor in Non-Small Cell Lung Cancer in Japan CARLSBAD, Calif., Sept. 10, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the Japan Ministry of Health, Labour and Welfare (MHLW), Japan’s regulatory agency, has granted approval for the Oncomine Dx Target Test as... Read more